StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04−0.05 (-4.59%)

Close on Nov 17, 2026Market cap $9.37MP/E –Yield –

Lisata Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Lisata Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$12.32M. For fiscal 2025 it was -$15.95M. The highest annual figure on record is -$8.48M in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.95M–
FY2024Dec 31, 2024-$19.36M–
FY2023Dec 31, 2023-$20.03M–
FY2022Dec 31, 2022-$21.17M–
FY2021Dec 31, 2021-$22.25M–
FY2020Dec 31, 2020-$8.82M–
FY2019Dec 31, 2019-$18.88M–
FY2018Dec 31, 2018-$19.99M–
FY2017Dec 31, 2017-$20.88M–
FY2016Dec 31, 2016-$23.67M–
FY2015Dec 31, 2015-$39.26M–
FY2014Dec 31, 2014-$46.90M–
FY2013Dec 31, 2013-$27.10M–
FY2012Dec 31, 2012-$13.85M–
FY2011Dec 31, 2011-$20.93M–
FY2010Dec 31, 2010-$8.48M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.65M–
Q1 FY2026Mar 31, 2026-$3.08M–
Q4 FY2025Dec 31, 2025-$3.25M–
Q3 FY2025Sep 30, 2025-$3.34M–
Q2 FY2025Jun 30, 2025-$3.96M–
Q1 FY2025Mar 31, 2025-$5.40M–
Q4 FY2024Dec 31, 2024-$4.53M–
Q3 FY2024Sep 30, 2024-$2.52M–
Q2 FY2024Jun 30, 2024-$5.28M–
Q1 FY2024Mar 31, 2024-$7.03M–
Q4 FY2023Dec 31, 2023-$4.07M–
Q3 FY2023Sep 30, 2023-$3.58M–
Q2 FY2023Jun 30, 2023-$4.18M–
Q1 FY2023Mar 31, 2023-$8.20M–
Q4 FY2022Dec 31, 2022-$6.47M–
Q3 FY2022Sep 30, 2022-$4.00M–
Q2 FY2022Jun 30, 2022-$5.06M–
Q1 FY2022Mar 31, 2022-$5.64M–
Q4 FY2021Dec 31, 2021-$4.60M–
Q3 FY2021Sep 30, 2021-$5.04M–
Q2 FY2021Jun 30, 2021-$4.63M-202.8%
Q1 FY2021Mar 31, 2021-$7.98M–
Q4 FY2020Dec 31, 2020-$5.57M–
Q3 FY2020Sep 30, 2020-$3.52M–
Q2 FY2020Jun 30, 2020$4.50M–
Q1 FY2020Mar 31, 2020-$4.24M–
Q4 FY2019Dec 31, 2019-$4.22M–
Q3 FY2019Sep 30, 2019-$4.46M–
Q2 FY2019Jun 30, 2019-$4.72M–
Q1 FY2019Mar 31, 2019-$5.49M–
Q4 FY2018Dec 31, 2018-$3.04M–
Q3 FY2018Sep 30, 2018-$4.76M–
Q2 FY2018Jun 30, 2018-$5.89M–
Q1 FY2018Mar 31, 2018-$6.30M–
Q4 FY2017Dec 31, 2017-$3.97M–
Q3 FY2017Sep 30, 2017-$6.33M–
Q2 FY2017Jun 30, 2017-$488.49K–
Q1 FY2017Mar 31, 2017-$10.09M–
Q4 FY2016Dec 31, 2016-$3.38M–
Q3 FY2016Sep 30, 2016-$5.72M–

More Lisata Therapeutics figures

See a number that looks wrong?